MTNR1B gene polymorphisms and susceptibility to Type 2 Diabetes: A pilot study in South Indians

Gene

Volumn 566, Issue 2, 2015, Pages 189-193

  Salman, Mohammed ^a,b   Dasgupta, Shruti ^b   Cholendra, A ^c   Venugopal, P N ^d   Lakshmi, G L ^a   Xaviour, D ^a   Rao, Jayashankar ^a   D'Souza, Cletus J M ^b  

^a Southern Regional Centre   (India)

^b UNIVERSITY OF MYSORE   (India)

^c SRI VENKATESWARA UNIVERSITY   (India)

^d North Regional Center   (India)

Author keywords

Fasting glucose; MTNR1B gene; Single nucleotide polymorphisms; South India; Type 2 Diabetes

Indexed keywords

GLUCOSE; MELATONIN; MELATONIN 2 RECEPTOR; MTNR1B PROTEIN, HUMAN;

ADULT; AGED; ALLELISM; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MTNR1B; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HUMAN; INDIAN; INSULIN RELEASE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; PILOT STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; GENETICS; INDIA; MIDDLE AGED;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; HUMANS; INDIA; MIDDLE AGED; PILOT PROJECTS; POLYMORPHISM, GENETIC; RECEPTOR, MELATONIN, MT2;

EID: 84929964479     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.04.064     Document Type: Article

References (27)

1. American Diabetes, A. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004, 27(Suppl. 1):S5-S10.
2. Andersson E.A., Holst B., Sparso T., Grarup N., Banasik K., Holmkvist J., Jorgensen T., Borch-Johnsen K., Egerod K.L., Lauritzen T., Sorensen T.I., Bonnefond A., Meyre D., Froguel P., Schwartz T.W., Pedersen O., Hansen T. MTNR1B G24E variant associates with BMI and fasting plasma glucose in the general population in studies of 22,142 Europeans. Diabetes 2010, 59:1539-1548.
3. Been L.F., Hatfield J.L., Shankar A., Aston C.E., Ralhan S., Wander G.S., Mehra N.K., Singh J.R., Mulvihill J.J., Sanghera D.K. A low frequency variant within the GWAS locus of MTNR1B affects fasting glucose concentrations: genetic risk is modulated by obesity. Nutr. Metab. Cardiovasc. Dis. 2012, 22:944-951.
4. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 1995, 57(1):289-300.
5. Bonnefond A., Clement N., Fawcett K., Yengo L., Vaillant E., Guillaume J.L., Dechaume A., Payne F., Roussel R., Czernichow S., Hercberg S., Hadjadj S., Balkau B., Marre M., Lantieri O., Langenberg C., Bouatia-Naji N., Meta-Analysis of, G., Insulin-Related Traits, C., Charpentier G., Vaxillaire M., Rocheleau G., Wareham N.J., Sladek R., McCarthy M.I., Dina C., Barroso I., Jockers R., Froguel P. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat. Genet. 2012, 44:297-301.
6. Bouatia-Naji N., Bonnefond A., Cavalcanti-Proenca C., Sparso T., Holmkvist J., Marchand M., Delplanque J., Lobbens S., Rocheleau G., Durand E., De Graeve F., Chevre J.C., Borch-Johnsen K., Hartikainen A.L., Ruokonen A., Tichet J., Marre M., Weill J., Heude B., Tauber M., Lemaire K., Schuit F., Elliott P., Jorgensen T., Charpentier G., Hadjadj S., Cauchi S., Vaxillaire M., Sladek R., Visvikis-Siest S., Balkau B., Levy-Marchal C., Pattou F., Meyre D., Blakemore A.I., Jarvelin M.R., Walley A.J., Hansen T., Dina C., Pedersen O., Froguel P. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat. Genet. 2009, 41:89-94.
7. Chambers J.C., Zhang W., Zabaneh D., Sehmi J., Jain P., McCarthy M.I., Froguel P., Ruokonen A., Balding D., Jarvelin M.R., Scott J., Elliott P., Kooner J.S. Common genetic variation near melatonin receptor MTNR1B contributes to raised plasma glucose and increased risk of type 2 diabetes among Indian Asians and European Caucasians. Diabetes 2009, 58:2703-2708.
8. Espino J., Pariente J.A., Rodriguez A.B. Role of melatonin on diabetes-related metabolic disorders. World J. Diabetes 2011, 2:82-91.
9. Herder C., Roden M. Genetics of type 2 diabetes: pathophysiologic and clinical relevance. Eur. J. Clin. Invest. 2011, 41:679-692.
10. Ingelsson E., Langenberg C., Hivert M.F., Prokopenko I., Lyssenko V., Dupuis J., Magi R., Sharp S., Jackson A.U., Assimes T.L., Shrader P., Knowles J.W., Zethelius B., Abbasi F.A., Bergman R.N., Bergmann A., Berne C., Boehnke M., Bonnycastle L.L., Bornstein S.R., Buchanan T.A., Bumpstead S.J., Bottcher Y., Chines P., Collins F.S., Cooper C.C., Dennison E.M., Erdos M.R., Ferrannini E., Fox C.S., Graessler J., Hao K., Isomaa B., Jameson K.A., Kovacs P., Kuusisto J., Laakso M., Ladenvall C., Mohlke K.L., Morken M.A., Narisu N., Nathan D.M., Pascoe L., Payne F., Petrie J.R., Sayer A.A., Schwarz P.E., Scott L.J., Stringham H.M., Stumvoll M., Swift A.J., Syvanen A.C., Tuomi T., Tuomilehto J., Tonjes A., Valle T.T., Williams G.H., Lind L., Barroso I., Quertermous T., Walker M., Wareham N.J., Meigs J.B., McCarthy M.I., Groop L., Watanabe R.M., Florez J.C., investigators, M. Detailed physiologic characterization reveals diverse mechanisms for novel genetic loci regulating glucose and insulin metabolism in humans. Diabetes 2010, 59:1266-1275.
11. Langenberg C., Pascoe L., Mari A., Tura A., Laakso M., Frayling T.M., Barroso I., Loos R.J., Wareham N.J., Walker M., Consortium, R. Common genetic variation in the melatonin receptor 1B gene (MTNR1B) is associated with decreased early-phase insulin response. Diabetologia 2009, 52:1537-1542.
12. Lyssenko V., Nagorny C.L., Erdos M.R., Wierup N., Jonsson A., Spegel P., Bugliani M., Saxena R., Fex M., Pulizzi N., Isomaa B., Tuomi T., Nilsson P., Kuusisto J., Tuomilehto J., Boehnke M., Altshuler D., Sundler F., Eriksson J.G., Jackson A.U., Laakso M., Marchetti P., Watanabe R.M., Mulder H., Groop L. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat. Genet. 2009, 41:82-88.
13. McMullan C.J., Schernhammer E.S., Rimm E.B., Hu F.B., Forman J.P. Melatonin secretion and the incidence of type 2 diabetes. JAMA 2013, 309:1388-1396.
14. Moorjani P., Thangaraj K., Patterson N., Lipson M., Loh P.R., Govindaraj P., Berger B., Reich D., Singh L. Genetic evidence for recent population mixture in India. Am. J. Hum. Genet. 2013, 93:422-438.
15. Peschke E., Muhlbauer E., Musshoff U., Csernus V.J., Chankiewitz E., Peschke D. Receptor (MT(1)) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1. J. Pineal Res. 2002, 33:63-71.
16. Peschke E., Frese T., Chankiewitz E., Peschke D., Preiss U., Schneyer U., Spessert R., Muhlbauer E. Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J. Pineal Res. 2006, 40:135-143.
17. Peschke E., Stumpf I., Bazwinsky I., Litvak L., Dralle H., Muhlbauer E. Melatonin and type 2 diabetes - a possible link?. J. Pineal Res. 2007, 42:350-358.
18. Peschke E., Hofmann K., Bahr I., Streck S., Albrecht E., Wedekind D., Muhlbauer E. The insulin-melatonin antagonism: studies in the LEW.1AR1-iddm rat (an animal model of human type 1 diabetes mellitus). Diabetologia 2011, 54:1831-1840.
19. Peschke E., Bahr I., Muhlbauer E. Melatonin and pancreatic islets: interrelationships between melatonin, insulin and glucagon. Int. J. Mol. Sci. 2013, 14:6981-7015.
20. Prokopenko I., Langenberg C., Florez J.C., Saxena R., Soranzo N., Thorleifsson G., Loos R.J., Manning A.K., Jackson A.U., Aulchenko Y., Potter S.C., Erdos M.R., Sanna S., Hottenga J.J., Wheeler E., Kaakinen M., Lyssenko V., Chen W.M., Ahmadi K., Beckmann J.S., Bergman R.N., Bochud M., Bonnycastle L.L., Buchanan T.A., Cao A., Cervino A., Coin L., Collins F.S., Crisponi L., de Geus E.J., Dehghan A., Deloukas P., Doney A.S., Elliott P., Freimer N., Gateva V., Herder C., Hofman A., Hughes T.E., Hunt S., Illig T., Inouye M., Isomaa B., Johnson T., Kong A., Krestyaninova M., Kuusisto J., Laakso M., Lim N., Lindblad U., Lindgren C.M., McCann O.T., Mohlke K.L., Morris A.D., Naitza S., Orru M., Palmer C.N., Pouta A., Randall J., Rathmann W., Saramies J., Scheet P., Scott L.J., Scuteri A., Sharp S., Sijbrands E., Smit J.H., Song K., Steinthorsdottir V., Stringham H.M., Tuomi T., Tuomilehto J., Uitterlinden A.G., Voight B.F., Waterworth D., Wichmann H.E., Willemsen G., Witteman J.C., Yuan X., Zhao J.H., Zeggini E., Schlessinger D., Sandhu M., Boomsma D.I., Uda M., Spector T.D., Penninx B.W., Altshuler D., Vollenweider P., Jarvelin M.R., Lakatta E., Waeber G., Fox C.S., Peltonen L., Groop L.C., Mooser V., Cupples L.A., Thorsteinsdottir U., Boehnke M., Barroso I., et al. Variants in MTNR1B influence fasting glucose levels. Nat. Genet. 2009, 41:77-81.
21. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575.
22. Sohani Z.N., Deng W.Q., Pare G., Meyre D., Gerstein H.C., Anand S.S. Does genetic heterogeneity account for the divergent risk of type 2 diabetes in South Asian and white European populations?. Diabetologia 2014, 57:2270-2281.
23. Staiger H., Machicao F., Schafer S.A., Kirchhoff K., Kantartzis K., Guthoff M., Silbernagel G., Stefan N., Haring H.U., Fritsche A. Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function. PLoS One 2008, 3:e3962.
24. Stumpf I., Muhlbauer E., Peschke E. Involvement of the cGMP pathway in mediating the insulin-inhibitory effect of melatonin in pancreatic beta-cells. J. Pineal Res. 2008, 45:318-327.
25. Sung H., Jung M., Eom Y.-B., Lee J.-E., Sull J., Jee S. Effects of MTNR1B variants on fasting glucose levels in a Korean population. Genes Genomics 2012, 34:103-106.
26. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
27. Xia Q., Chen Z.-X., Wang Y.-C., Ma Y.-S., Zhang F., Che W., Fu D., Wang X.-F. Association between the melatonin receptor 1B gene polymorphism on the risk of type 2 diabetes, impaired glucose regulation: a meta-analysis. PLoS One 2012, 7:e50107.